Join in the future of regenerative care.

Designed to deliver an optimal experience in the comfort of your home, this concierge service administers exosomes safely through an intravenous (IV) push by a highly trained provider. This allows the exosomes to circulate throughout the bloodstream and reach various tissues and organs.

IMPORTANT NOTICE: Stem cell-derived exosomes are not currently approved by the FDA for use in medical treatments.

Concierge Plans:​

About Concierge Intravenous (IV) Administration

Exosomes are small vesicles released by stem cells. As a result of their unique structure, they contain large amounts of growth factors, cytokines, and other substances with high regenerative potential. Exosomes use this structure to fuse with other cells in the body and release their contents. By transferring signaling molecules, the contents of the exosomes, such as growth factors, cytokines, and mRNA, can then help the cell heal itself. Cell-free exosome products don’t contain any live cells by definition.

AVAILABLE SIZE in: 5mL (100Bn Exosomes)

COA DOCUMENTATION
Each batch you receive comes with a Certificate of Analysis, ensuring the quality of our products. All products are made at CGMP (Current Good Manufacturing Practice) facilities that are regulated by the FDA.

CGMP MANUFACTURING & FDA
360ReGen partners with local Medical Research Institutions to perform cutting-edge research on the regenerative properties of stem cell-derived exosomes and their contents. Together with our researchers, we are laying the foundation for the development of FDA-approved clinical exosome products. FDA Masterfile available upon request